Several Chinese nationals, including two scientists who worked for GlaxoSmithKline, charged with stealing cancer medication trade secrets from the drugmaker are set to stand trial next year.

U.S. District Judge Joel H. Slomsky of the Eastern District of Pennsylvania slated Oct. 22, 2018, as the trial date for the accused.